428 related articles for article (PubMed ID: 16307853)
1. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
Trune DR; Kempton JB; Gross ND
Hear Res; 2006 Feb; 212(1-2):22-32. PubMed ID: 16307853
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice.
Gross ND; Kempton JB; Trune DR
Laryngoscope; 2002 Feb; 112(2):298-303. PubMed ID: 11889387
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice.
Trune DR; Kempton JB; Kessi M
Laryngoscope; 2000 Nov; 110(11):1902-6. PubMed ID: 11081607
[TBL] [Abstract][Full Text] [Related]
4. Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.
Trune DR; Kempton JB
Audiol Neurootol; 2009; 14(6):423-31. PubMed ID: 19923812
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice.
Trune DR; Kempton JB; Harrison AR; Wobig JL
Hear Res; 2007 Apr; 226(1-2):209-17. PubMed ID: 17098384
[TBL] [Abstract][Full Text] [Related]
6. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Fas(lpr) autoimmune mice.
Trune DR; Kempton JB
Hear Res; 2001 May; 155(1-2):9-20. PubMed ID: 11335072
[TBL] [Abstract][Full Text] [Related]
8. Steroid-responsive cochlear dysfunction in the MRL/lpr autoimmune mouse.
Wobig RJ; Kempton Jb; Trune DR
Otolaryngol Head Neck Surg; 1999 Oct; 121(4):344-7. PubMed ID: 10504585
[TBL] [Abstract][Full Text] [Related]
9. Steroid treatment in young MRL.MpJ-Fas(lpr) autoimmune mice prevents cochlear dysfunction.
Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
Hear Res; 1999 Nov; 137(1-2):167-73. PubMed ID: 10545644
[TBL] [Abstract][Full Text] [Related]
10. Steroid treatment improves cochlear function in the MRL.MpJ-Fas(lpr) autoimmune mouse.
Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
Hear Res; 1999 Nov; 137(1-2):160-6. PubMed ID: 10545643
[TBL] [Abstract][Full Text] [Related]
11. Low dose combination steroids control autoimmune mouse hearing loss.
Trune DR; Kempton JB
J Neuroimmunol; 2010 Dec; 229(1-2):140-5. PubMed ID: 20800906
[TBL] [Abstract][Full Text] [Related]
12. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
[TBL] [Abstract][Full Text] [Related]
14. Normal cochlear function in mdx and mdx(Cv3) Duchenne muscular dystrophy mouse models.
Pillers DA; Duncan NM; Dwinnell SJ; Rash SM; Kempton JB; Trune DR
Laryngoscope; 1999 Aug; 109(8):1310-2. PubMed ID: 10443839
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma.
Hori R; Nakagawa T; Sugimoto Y; Sakamoto T; Yamamoto N; Hamaguchi K; Ito J
Neuroscience; 2009 Jun; 160(4):813-9. PubMed ID: 19303430
[TBL] [Abstract][Full Text] [Related]
16. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB mediated glucocorticoid response in the inner ear after acoustic trauma.
Tahera Y; Meltser I; Johansson P; Bian Z; Stierna P; Hansson AC; Canlon B
J Neurosci Res; 2006 May; 83(6):1066-76. PubMed ID: 16493680
[TBL] [Abstract][Full Text] [Related]
18. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
Van Wijk F; Staecker H; Keithley E; Lefebvre PP
Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
[TBL] [Abstract][Full Text] [Related]
19. Excretion of electrolytes in Brown Norway and Fischer 344 rats: effects of adrenalectomy and of mineralocorticoid and glucocorticoid receptor ligands.
Marissal-Arvy N; Mormède P
Exp Physiol; 2004 Nov; 89(6):753-65. PubMed ID: 15364879
[TBL] [Abstract][Full Text] [Related]
20. Effects of immunosuppression on the development of cochlear disease in the MRL-Fas(lpr) mouse.
Ruckenstein MJ; Sarwar A; Hu L; Shami H; Marion TN
Laryngoscope; 1999 Apr; 109(4):626-30. PubMed ID: 10201753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
